Pancreatic Cancer Action Networkでは、
The RFAs note:
(Precision Medicine) There are no restrictions on citizenship or country of origin, but note that the Precision Promise Clinical Trial Consortium currently operates only in the United States.
(Early Detection) There are no restrictions on citizenship or country of origin, but note that the new-onset diabetes cohort is currently designed to operate only in the United States.
The other funding opportunities listed in this month’s News & Updates are through the NCI/NIH, and therefore do not accept international applications.
【募集概要】
1．すい臓がんのプレシジョンメディシンに資する研究（公募中）
OPEN Pancreatic Cancer Action Network Precision Medicine Targeted Grant
Amount: Up to $1,000,000
Supports translational and clinically relevant projects that are identified as next steps for our Precision Promise initiative
Application deadline: February 15, 2017, Noon EST
(Precision Medicine) There are no restrictions on citizenship or country of origin, but note that the Precision Promise Clinical Trial Consortium currently operates only in the United States.
Apply now:https://proposalcentral.altum.com/
2．すい臓がんの早期発見に資する研究(公募中）
OPEN Pancreatic Cancer Action Network Early Detection Targeted Grant
Amount: Up to $1,000,000
Supports studies to utilize a cohort of new onset diabetics with high risk of sporadic pancreatic cancer; projects will focus on blood biomarkers or imaging approaches
Application deadline: February 22, 2017, Noon EST
（Early Detection) There are no restrictions on citizenship or country of origin, but note that the new-onset diabetes cohort is currently designed to operate only in the United States.
Apply now:https://proposalcentral.altum.com/
【問い合わせ先】
Building a Community for Progress
In addition to receiving financial support for their research, grantees participate in the Pancreatic Cancer Action Network’s Community for Progress. Our mentorship program connects grantees with leading scientists in the field. Ongoing career support activities offer opportunities for education and professional development to help keep our community of researchers committed and involved.
For more information, please email このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。 or call 310-725-0025.
